Tag: oldAge

Articles

• Breast cancer in old age
• Triple negative breast cancer prognosis according to age at diagnosis

News

10/08/17

Use of metformin linked to lower recurrence among older BC survivors

07/04/16

Radiotherapy after lumpectomy improves survival in older ER- women

05/26/14

BC surgery should not be omitted in relatively healthy older women

03/04/10

Delay in radiotherapy increases risk of local recurrence

Studies

• Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort Cite
  Pla H, Felip E, Obadia V, Pernas S, Viñas G, Margelí M, et al. Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort. Clinical and Translational Oncology. Springer Science and Business Media LLC; 2024; 10.1007/s12094-024-03399-3
• Predicting the Survival Benefit of Radiotherapy in Elderly Breast Cancer Patients: A Population-Based Analysis Cite
  Li M, Tang J, Pan X, Zhang D. Predicting the Survival Benefit of Radiotherapy in Elderly Breast Cancer Patients: A Population-Based Analysis. Journal of Surgical Research. Elsevier BV; 2024; 297:26-40 10.1016/j.jss.2024.02.002
• Prognosis and Adjusting Factors in Elderly Patients With Triple-Negative Breast Cancer: Comparing With Young and Middle Age Groups Cite
  You YH, Kim MK, Lee JY. Prognosis and Adjusting Factors in Elderly Patients With Triple-Negative Breast Cancer: Comparing With Young and Middle Age Groups. Clinical Breast Cancer. Elsevier BV; 2024; 10.1016/j.clbc.2024.01.016
• A Prospective Study of Sentinel Node Biopsy Omission in Women Age ≥ 65 Years with ER+ Breast Cancer Cite
  Chung AP, Dang CM, Karlan SR, Amersi FF, Phillips EM, Boyle MK, et al. A Prospective Study of Sentinel Node Biopsy Omission in Women Age ≥ 65 Years with ER+ Breast Cancer. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2024; 10.1245/s10434-024-15000-w
• Health benefits and harms of mammography screening in older women (75+ years)—a systematic review Cite
  Mathieu E, Noguchi N, Li T, Barratt AL, Hersch JK, De Bock GH, et al. Health benefits and harms of mammography screening in older women (75+ years)—a systematic review. British Journal of Cancer. Springer Science and Business Media LLC; 2023; 130:275-296 10.1038/s41416-023-02504-7
• Omission of Radiotherapy in Women > 60 Years Old After Breast Conserving Surgery for Breast Cancer is Non-Inferior in Terms of Local Recurrence: A Retrospective Cohort Study Cite
  Sachoulidou A, Apostolidou F, Fronis C, Misailidou D, Bozoglou A, Tataridou TA, et al. Omission of Radiotherapy in Women > 60 Years Old After Breast Conserving Surgery for Breast Cancer is Non-Inferior in Terms of Local Recurrence: A Retrospective Cohort Study. European Journal of Breast Health. Galenos Yayinevi; 2024; 20:38-44 10.4274/ejbh.galenos.2023.2023-9-5
• Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancer Cite
  Chadha M, White J, Swain SM, Rakovitch E, Jagsi R, Whelan T, et al. Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancer. npj Breast Cancer. Springer Science and Business Media LLC; 2023; 9 10.1038/s41523-023-00591-6
• Omitting radiotherapy in elderly breast cancer patients: Valid strategy or illusory hope? Cite
  Kouhen F. Omitting radiotherapy in elderly breast cancer patients: Valid strategy or illusory hope?. The Breast. Elsevier BV; 2023;:103598 10.1016/j.breast.2023.103598
• The Impact of Frailty on Adjuvant Therapies Not Offered to or Declined by Breast Cancer Surgery Patients Cite
  Solsky I, Cairns A, Martin T, Perko A, Friday S, Levine E, et al. The Impact of Frailty on Adjuvant Therapies Not Offered to or Declined by Breast Cancer Surgery Patients. The American Surgeon™. SAGE Publications; 2023; 10.1177/00031348231198116
• The effect of adjuvant radiotherapy after breast-conserving surgery in elderly women with T1-2N0 estrogen receptor-negative breast cancer Cite
  Chen C, Wang R, Wang B, Wu Y, Jiang J. The effect of adjuvant radiotherapy after breast-conserving surgery in elderly women with T1-2N0 estrogen receptor-negative breast cancer. PLOS ONE. Public Library of Science (PLoS); 2023; 18:e0288078 10.1371/journal.pone.0288078
• Changes in the incidence of early-onset breast cancer in Germany between 2010 and 2022 Cite
  Gremke N, Wagner U, Kalder M, Kostev K. Changes in the incidence of early-onset breast cancer in Germany between 2010 and 2022. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-023-07048-1
• Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70 Years of Age? A National Cancer Database Analysis of Sentinel Node Practice Patterns Cite
  Goldhaber NH, O’Keefe T, Kang J, Douglas S, Blair SL. Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70 Years of Age? A National Cancer Database Analysis of Sentinel Node Practice Patterns. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2023; 10.1245/s10434-023-13886-6
• The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy Cite
  Waaijer ME, Lemij AA, de Boer AZ, Bastiaannet E, van den Bos F, Derks MG, et al. The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-023-07029-4
• Plasma levels of interleukin‐6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study Cite
  Mandelblatt JS, Small BJ, Zhou X, Nakamura ZM, Cohen HJ, Ahles TA, et al. Plasma levels of interleukin‐6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study. Cancer. Wiley; 2023; 129:2409-2421 10.1002/cncr.34784
• Predictive biological factors for late survival in patients with HER2-positive breast cancer Cite
  Kang Y, Oh SJ, Bae SY, Kim E, Lee Y, Park EH, et al. Predictive biological factors for late survival in patients with HER2-positive breast cancer. Scientific Reports. Springer Science and Business Media LLC; 2023; 13 10.1038/s41598-023-38200-y
• Breast cancer mortality in 500 000 women with early invasive breast cancer in England, 1993-2015: population based observational cohort study Cite
  Taylor C, McGale P, Probert J, Broggio J, Charman J, Darby SC, et al. Breast cancer mortality in 500 000 women with early invasive breast cancer in England, 1993-2015: population based observational cohort study. BMJ. BMJ; 2023;:e074684 10.1136/bmj-2022-074684
• Associations Between Hospital Volume and Overall Survival After Surgery in Older Patients with Breast Cancer Cite
  Thalji SZ, Cortina CS, Frebault J, Cho Y, Thorgerson A, Bergom CR, et al. Associations Between Hospital Volume and Overall Survival After Surgery in Older Patients with Breast Cancer. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2023; 10.1245/s10434-023-13725-8
• Epigenetic aging in older breast cancer survivors and non‐cancer controls: preliminary findings from the Thinking and Living with Cancer (TLC) Study Cite
  Rentscher KE, Bethea TN, Zhai W, Small BJ, Zhou X, Ahles TA, et al. Epigenetic aging in older breast cancer survivors and non‐cancer controls: preliminary findings from the Thinking and Living with Cancer (TLC) Study. Cancer. Wiley; 2023; 10.1002/cncr.34818
• Surgical Treatments for Ductal Carcinoma In Situ (DCIS) in Elderly Patients Cite
  BUONOMO OC, PELLICCIARO M, MATERAZZO M, BERARDI S, GIGLIOTTI PE, CASPI J, et al. Surgical Treatments for Ductal Carcinoma In Situ (DCIS) in Elderly Patients. Anticancer Research. Anticancer Research USA Inc.; 2023; 43:1555-1562 10.21873/anticanres.16305
• Cognitive function is mediated by deficit accumulation in older, long-term breast cancer survivors Cite
  Ahles TA, Schofield E, Li Y, Ryan E, Orlow I, Patel SK, et al. Cognitive function is mediated by deficit accumulation in older, long-term breast cancer survivors. Journal of Cancer Survivorship. Springer Science and Business Media LLC; 2023; 10.1007/s11764-023-01365-6
• Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis Cite
  Zhang H, Barner JC, Moczygemba LR, Rascati KL, Park C, Kodali D. Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis. Breast Cancer. Springer Science and Business Media LLC; 2023; 10.1007/s12282-023-01441-w
• The risks of cancer in older women with BRCA pathogenic variants: How far have we come? Cite
  Metcalfe KA, Gronwald J, Tung NM, McCuaig JM, Eisen A, Elser C, et al. The risks of cancer in older women with BRCA pathogenic variants: How far have we come?. Cancer. Wiley; 2022; 129:901-907 10.1002/cncr.34615
• Association between Endocrine Therapy and Cognitive Decline in Older Women with Early Breast Cancer: Findings from the Prospective CLIMB Study Cite
  Baltussen JC, Derks MG, Lemij AA, de Glas NA, Fiocco M, Linthorst-Niers EM, et al. Association between Endocrine Therapy and Cognitive Decline in Older Women with Early Breast Cancer: Findings from the Prospective CLIMB Study. European Journal of Cancer. Elsevier BV; 2023; 10.1016/j.ejca.2023.02.008
• Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer Cite
  Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM. Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer. New England Journal of Medicine. Massachusetts Medical Society; 2023; 388:585-594 10.1056/nejmoa2207586
• A real-world data retrospective cohort study of HER2-positive, early-stage breast cancer in patients 70 years of age or older: natural history, treatment patterns, and outcomes Cite
  Bari S, Li J, Kang D, Jameel Z, Czerniecki BJ, Costa RL. A real-world data retrospective cohort study of HER2-positive, early-stage breast cancer in patients 70 years of age or older: natural history, treatment patterns, and outcomes. Clinical Breast Cancer. Elsevier BV; 2023; 10.1016/j.clbc.2023.01.013
• Chemotherapy refusal and subsequent survival in healthy older women with high genomic risk estrogen receptor-positive breast cancer Cite
  White MJ, Kolbow M, Prathibha S, Praska C, Ankeny JS, LaRocca CJ, et al. Chemotherapy refusal and subsequent survival in healthy older women with high genomic risk estrogen receptor-positive breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-023-06862-x
• Aging a Decade in a Day: Age cutoff bias in adjuvant therapy allocation for early-stage breast cancer Cite
  Talcott WJ, Cain DM, Yang D, Mougalian SS, Evans SB. Aging a Decade in a Day: Age cutoff bias in adjuvant therapy allocation for early-stage breast cancer. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2023; 10.1016/j.ijrobp.2022.12.057
• Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE Trial Cite
  Sedrak MS, Sun C, Ji J, Cohen HJ, Gross CP, Tew WP, et al. Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE Trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2022; 10.1200/jco.22.01440
• An Examination of the Longitudinal Relationship Between Cognitive Function and Physical Activity Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study Cite
  Tometich DB, Mosher CE, Cyders M, McDonald BC, Saykin AJ, Small BJ, et al. An Examination of the Longitudinal Relationship Between Cognitive Function and Physical Activity Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study. Annals of Behavioral Medicine. Oxford University Press (OUP); 2022; 10.1093/abm/kaac048
• Geriatric Early-Stage Triple-negative Breast Cancer Patients in Low-risk Population: Omitting Chemotherapy Based on Nomogram Cite
  Zhou C, Xu L, Du Z, Lv Q. Geriatric Early-Stage Triple-negative Breast Cancer Patients in Low-risk Population: Omitting Chemotherapy Based on Nomogram. Clinical Breast Cancer. Elsevier BV; 2022; 10.1016/j.clbc.2022.08.013
• Survival outcomes for breast conserving surgery versus mastectomy among elderly women with breast cancer Cite
  Xie W, Cao M, Zhong Z, Huang Z, Gao X, Li Z. Survival outcomes for breast conserving surgery versus mastectomy among elderly women with breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2022; 10.1007/s10549-022-06725-x
• Age disparities in triple-negative breast cancer treatment and outcomes: An NCDB analysis Cite
  Drapalik LM, Estes A, Sarode AL, Cao L, Shenk RR, Jarrett CM, et al. Age disparities in triple-negative breast cancer treatment and outcomes: An NCDB analysis. Surgery. Elsevier BV; 2022; 172:821-830 10.1016/j.surg.2022.05.026
• Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks Cite
  Sorrenti V, Benedetti F, Buriani A, Fortinguerra S, Caudullo G, Davinelli S, et al. Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks. Pharmaceuticals. MDPI AG; 2022; 15:912 10.3390/ph15080912
• Long-term survival in elderly women receiving chemotherapy for non-metastatic breast cancer: a population-based analysis Cite
  Castelo M, Lu J, Paszat L, Veitch Z, Liu K, Scheer AS. Long-term survival in elderly women receiving chemotherapy for non-metastatic breast cancer: a population-based analysis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2022; 10.1007/s10549-022-06646-9
• Impact of Endocrine Therapy Adherence on Outcomes in Elderly Women with Early-Stage Breast Cancer Undergoing Lumpectomy Without Radiotherapy Cite
  Matar R, Sevilimedu V, Gemignani ML, Morrow M. Impact of Endocrine Therapy Adherence on Outcomes in Elderly Women with Early-Stage Breast Cancer Undergoing Lumpectomy Without Radiotherapy. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2022; 10.1245/s10434-022-11728-5
• Facility-Level Variation of Low-Value Breast Cancer Treatments in Older Women with Early-Stage Breast Cancer: Analysis of a Statewide Claims Registry Cite
  Bredbeck BC, Mott NM, Wang T, Sinco BR, Hughes TM, Nathan H, et al. Facility-Level Variation of Low-Value Breast Cancer Treatments in Older Women with Early-Stage Breast Cancer: Analysis of a Statewide Claims Registry. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2022; 10.1245/s10434-022-11631-z
• Metastasis patterns and prognosis in young breast cancer patients: a SEER database analysis Cite
  zhang w, Liu J, Zhang X, Yang C, Cao M, Zhang S, et al. Metastasis patterns and prognosis in young breast cancer patients: a SEER database analysis. Research Square Platform LLC; 2022; 10.21203/rs.3.rs-1434952/v1
• Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC) Cite
  Canelo-Aybar C, Posso M, Montero N, Solà I, Saz-Parkinson Z, Duffy SW, et al. Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC). British Journal of Cancer. Springer Science and Business Media LLC; 2021; 126:673-688 10.1038/s41416-021-01521-8
• Metastasis patterns and prognosis of octogenarians with metastatic breast cancer: A large-cohort retrospective study Cite
  Lv Z, Zhang W, Zhang Y, Zhong G, Zhang X, Yang Q, et al. Metastasis patterns and prognosis of octogenarians with metastatic breast cancer: A large-cohort retrospective study. PLOS ONE. Public Library of Science (PLoS); 2022; 17:e0263104 10.1371/journal.pone.0263104
• Age-related risk for second breast cancer and gynecological malignant neoplasms after differentiated thyroid cancer Cite
  Zhao X, Yang G, Zhang W, Dong Q, Yang Q. Age-related risk for second breast cancer and gynecological malignant neoplasms after differentiated thyroid cancer. Endocrine. Springer Science and Business Media LLC; 2022; 10.1007/s12020-022-02999-9
• Estimating Distributions of Breast Cancer Onset and Growth in a Swedish Mammography Screening Cohort Cite
  Strandberg R, Czene K, Eriksson M, Hall P, Humphreys K. Estimating Distributions of Breast Cancer Onset and Growth in a Swedish Mammography Screening Cohort. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2022;:cebp.1011.2021 10.1158/1055-9965.epi-21-1011
• Breast reconstruction is a viable option for older patients Cite
  Dolen UC, Law J, Tenenbaum MM, Myckatyn TM. Breast reconstruction is a viable option for older patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 191:77-86 10.1007/s10549-021-06389-z
• Can We Successfully De-Escalate Axillary Surgery in Women Aged ≥ 70 Years with Ductal Carcinoma in Situ or Early-Stage Breast Cancer Undergoing Mastectomy? Cite
  Matar R, Barrio AV, Sevilimedu V, Le T, Heerdt A, Morrow M, et al. Can We Successfully De-Escalate Axillary Surgery in Women Aged ≥ 70 Years with Ductal Carcinoma in Situ or Early-Stage Breast Cancer Undergoing Mastectomy?. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2022; 10.1245/s10434-021-11140-5
• Adjuvant Radiotherapy is Associated with an Increase of Survival of Old (Aged Over 80 Years) and Very Old (Aged Over 90 Years) Women with Breast Cancer Receiving Breast-Conserving Surgery Cite
  Zhang J, Sum S, Chang C, Hsu J, Chiang M, Lee T, et al. Adjuvant Radiotherapy is Associated with an Increase of Survival of Old (Aged Over 80 Years) and Very Old (Aged Over 90 Years) Women with Breast Cancer Receiving Breast-Conserving Surgery. Research Square Platform LLC; 2021; 10.21203/rs.3.rs-1133222/v1
• Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients? Cite
  Maltoni R, Ravaioli S, Bronte G, Mazza M, Cerchione C, Massa I, et al. Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients?. Translational Oncology. Elsevier BV; 2022; 15:101300 10.1016/j.tranon.2021.101300
• Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis Cite
  Small BJ, Lange M, Zhai W, Ahn J, Ahles TA, Carroll JE, et al. Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06455-6
• Is the oncotype DX test useful in elderly breast cancer patients: a subgroup analysis of real-life Italian PONDx study Cite
  Barni S, Cognetti F, Petrelli F. Is the oncotype DX test useful in elderly breast cancer patients: a subgroup analysis of real-life Italian PONDx study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06464-5
• Risk factors at five-year survival in grade 3 breast cancer: a retrospective observational study of the New Zealand population Cite
  Meharry S, Borotkanics R, Ramsaroop R, Merien F. Risk factors at five-year survival in grade 3 breast cancer: a retrospective observational study of the New Zealand population. BMC Public Health. Springer Science and Business Media LLC; 2021; 21 10.1186/s12889-021-12122-8
• Evaluation of Adjuvant Radiation and Endocrine Therapy in Elderly Patients with Early-Stage Breast Cancer Cite
  Ma S, Yu B, Oladeru O, Bartl A, Farrugia M, Fekrmandi F, et al. Evaluation of Adjuvant Radiation and Endocrine Therapy in Elderly Patients with Early-Stage Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2021; 111:e207-e208 10.1016/j.ijrobp.2021.07.734
• Adherence to Endocrine Therapy Predicts Short-Term Clinical Outcomes for Postmenopausal Women With Luminal B but Not Luminal A Breast Cancer Cite
  Fahey M, Mills M, Liveringhouse C, Ronica N, Diaz R. Adherence to Endocrine Therapy Predicts Short-Term Clinical Outcomes for Postmenopausal Women With Luminal B but Not Luminal A Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2021; 111:e206 10.1016/j.ijrobp.2021.07.730
• Aged Breast Extracellular Matrix Drives Mammary Epithelial Cells to an Invasive and Cancer‐Like Phenotype Cite
  Bahcecioglu G, Yue X, Howe E, Guldner I, Stack MS, Nakshatri H, et al. Aged Breast Extracellular Matrix Drives Mammary Epithelial Cells to an Invasive and Cancer‐Like Phenotype. Advanced Science. Wiley; 2021;:2100128 10.1002/advs.202100128
• The Trade-Off of Post-Mastectomy Radiotherapy Usage for the Breast Cancer Patients Aged 70 Years or Older: A Study Based on SEER Database Cite
  Lin J, Luo S, Zhang J, Song C. The Trade-Off of Post-Mastectomy Radiotherapy Usage for the Breast Cancer Patients Aged 70 Years or Older: A Study Based on SEER Database. Research Square Platform LLC; 2021; 10.21203/rs.3.rs-966806/v1
• Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME database Cite
  Annonay M, Gauquelin L, Geiss R, Ung M, Cristol-Dalstein L, Mouret-Reynier M, et al. Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME database. The Breast. Elsevier BV; 2021; 60:138-146 10.1016/j.breast.2021.09.011
• Association of Breast Density With Breast Cancer Risk Among Women Aged 65 Years or Older by Age Group and Body Mass Index Cite
  Advani SM, Zhu W, Demb J, Sprague BL, Onega T, Henderson LM, et al. Association of Breast Density With Breast Cancer Risk Among Women Aged 65 Years or Older by Age Group and Body Mass Index. JAMA Network Open. American Medical Association (AMA); 2021; 4:e2122810 10.1001/jamanetworkopen.2021.22810
• Oncologists’ perspectives on omission of sentinel lymph node biopsy in women >70 years with early-stage hormone receptor-positive breast cancer. Cite
  Minami CA, Bryan AF, Revette AC, Freedman RA, King TA, Mittendorf EA. Oncologists’ perspectives on omission of sentinel lymph node biopsy in women >70 years with early-stage hormone receptor-positive breast cancer.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2021; 39:48-48 10.1200/jco.2020.39.28_suppl.48
• Mediterranean Diet Food Components as Possible Adjuvant Therapies to Counteract Breast and Prostate Cancer Progression to Bone Metastasis Cite
  Maroni P, Bendinelli P, Fulgenzi A, Ferraretto A. Mediterranean Diet Food Components as Possible Adjuvant Therapies to Counteract Breast and Prostate Cancer Progression to Bone Metastasis. Biomolecules. MDPI AG; 2021; 11:1336 10.3390/biom11091336
• Metastasis patterns and prognosis in breast cancer patients aged ≥ 80 years: a SEER database analysis Cite
  Han Y, Sui Z, Jia Y, Wang H, Dong Y, Zhang H, et al. Metastasis patterns and prognosis in breast cancer patients aged ≥ 80 years: a SEER database analysis. Journal of Cancer. Ivyspring International Publisher; 2021; 12:6445-6453 10.7150/jca.63813
• Invasive Breast Cancer Treatment Patterns in Women Age 80 and Over: A Report from the National Cancer Database Cite
  Frebault J, Bergom C, Cortina CS, Shukla ME, Zhang Y, Huang C, et al. Invasive Breast Cancer Treatment Patterns in Women Age 80 and Over: A Report from the National Cancer Database. Clinical Breast Cancer. Elsevier BV; 2021; 10.1016/j.clbc.2021.07.005
• Acute toxicity and tolerability of anthracycline-based chemotherapy regimens in older versus younger patients with breast cancer: real-world data Cite
  Monteiro AR, Garcia AR, Póvoa S, Soares RF, Macedo F, Pereira TC, et al. Acute toxicity and tolerability of anthracycline-based chemotherapy regimens in older versus younger patients with breast cancer: real-world data. Supportive Care in Cancer. Springer Science and Business Media LLC; 2020; 29:2347-2353 10.1007/s00520-020-05766-6
• Postmastectomy radiation therapy and survival outcome in older patients with T1-2N1 breast cancer Cite
  Luo C, Zhong X, Luo T, Zheng H. Postmastectomy radiation therapy and survival outcome in older patients with T1-2N1 breast cancer. The Breast. Elsevier BV; 2021; 10.1016/j.breast.2021.08.002
• Impact of Choosing Wisely Recommendations on Sentinel Lymph Node Biopsy and Postoperative Radiation Rates in Women Over Age 70 Years with Hormone-Positive Breast Cancer Cite
  Thompson J, Le J, Hop A, Melnik M, Paulson J, Wright GP. Impact of Choosing Wisely Recommendations on Sentinel Lymph Node Biopsy and Postoperative Radiation Rates in Women Over Age 70 Years with Hormone-Positive Breast Cancer. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2021; 10.1245/s10434-021-10460-w
• Risk of Late-Onset Breast Cancer in Genetically Predisposed Women Cite
  Boddicker NJ, Hu C, Weitzel JN, Kraft P, Nathanson KL, Goldgar DE, et al. Risk of Late-Onset Breast Cancer in Genetically Predisposed Women. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2021;:JCO.21.00531 10.1200/jco.21.00531
• Inflammatory Breast Cancer at the Extremes of Age Cite
  Adesoye T, Babayemi O, Postlewait LM, DeSnyder SM, Sun SX, Woodward WA, et al. Inflammatory Breast Cancer at the Extremes of Age. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2021; 10.1245/s10434-021-10453-9
• Systemic therapy and prognosis of older patients with stage II/III breast cancer: A large-scale analysis of the Japanese Breast Cancer Registry Cite
  Yamada A, Kumamaru H, Shimizu C, Taira N, Nakayama K, Miyashita M, et al. Systemic therapy and prognosis of older patients with stage II/III breast cancer: A large-scale analysis of the Japanese Breast Cancer Registry. European Journal of Cancer. Elsevier BV; 2021; 154:157-166 10.1016/j.ejca.2021.06.006
• Breast Cancer Treatment Patterns in Women Age 80 and Over: A Report from the National Cancer Database Cite
  Frebault J, Bergom C, Cortina CS, Shukla ME, Zhang Y, Huang C, et al. Breast Cancer Treatment Patterns in Women Age 80 and Over: A Report from the National Cancer Database. Clinical Breast Cancer. Elsevier BV; 2021; 10.1016/j.clbc.2021.07.005
• Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns Cite
  Lima SM, Kehm RD, Terry MB. Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns. EClinicalMedicine. Elsevier BV; 2021; 38:100985 10.1016/j.eclinm.2021.100985
• Cognitive dysfunction prevalence and associated factors in older breast cancer survivors Cite
  Crouch A, Champion VL, Unverzagt FW, Pressler SJ, Huber L, Moser LR, et al. Cognitive dysfunction prevalence and associated factors in older breast cancer survivors. Journal of Geriatric Oncology. Elsevier BV; 2021; 10.1016/j.jgo.2021.07.001
• Observational cohort study in older women with early breast cancer: Use of radiation therapy and impact on health-related quality of life and mortality Cite
  Battisti NML, Hatton MQ, Reed MW, Herbert E, Morgan JL, Bradburn M, et al. Observational cohort study in older women with early breast cancer: Use of radiation therapy and impact on health-related quality of life and mortality. Radiotherapy and Oncology. Elsevier BV; 2021; 161:166-176 10.1016/j.radonc.2021.06.021
• Breast Cancer in Women Aged 75 Years and Older Cite
  Bulut G, Güner Oytun M, Almuradova E, Balam Doğu B, Karaca B. Breast Cancer in Women Aged 75 Years and Older. European Journal of Geriatrics and Gerontology. Galenos Yayinevi; 2021; 0:0-0 10.4274/ejgg.galenos.2020.413
• Impact of chemotherapy on cognitive functioning in older patients with HER2-positive breast cancer: a sub-study in the RESPECT trial Cite
  Hagiwara Y, Sawaki M, Uemura Y, Kawahara T, Shimozuma K, Ohashi Y, et al. Impact of chemotherapy on cognitive functioning in older patients with HER2-positive breast cancer: a sub-study in the RESPECT trial. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06253-0
• Effects of Adjuvant Endocrine Therapy Adherence and Radiation on Recurrence and Survival Among Older Women with Early-Stage Breast Cancer Cite
  Showalter SL, Meneveau MO, Keim-Malpass J, Camacho TF, Squeo G, Anderson RT. Effects of Adjuvant Endocrine Therapy Adherence and Radiation on Recurrence and Survival Among Older Women with Early-Stage Breast Cancer. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2021; 10.1245/s10434-021-10064-4
• Risk of venous thromboembolism and endocrine therapy in older women with breast cancer in the United States Cite
  Faiz AS, Guo S, Kaveney A, Philipp CS. Risk of venous thromboembolism and endocrine therapy in older women with breast cancer in the United States. Blood Coagulation & Fibrinolysis. Ovid Technologies (Wolters Kluwer Health); 2021; Publish Ahead of Print 10.1097/mbc.0000000000001043
• Identification of a Positive Association between Mammary Adipose Cholesterol Content and Indicators of Breast Cancer Aggressiveness in a French Population Cite
  Goupille C, Ouldamer L, Pinault M, Guimares C, Arbion F, Jourdan ML, et al. Identification of a Positive Association between Mammary Adipose Cholesterol Content and Indicators of Breast Cancer Aggressiveness in a French Population. The Journal of Nutrition. Oxford University Press (OUP); 2021; 10.1093/jn/nxaa432
• Sentinel Node Biopsy Should Not be Routine in Older Patients with ER-Positive HER2-Negative Breast Cancer Who Are Willing and Able to Take Hormone Therapy Cite
  McKevitt E, Cheifetz R, DeVries K, Laws A, Warburton R, Gondara L, et al. Sentinel Node Biopsy Should Not be Routine in Older Patients with ER-Positive HER2-Negative Breast Cancer Who Are Willing and Able to Take Hormone Therapy. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2021; 10.1245/s10434-021-09839-6
• Five-Year Adjuvant Endocrine Therapy Adherence Trajectories Among Women With Breast Cancer: A Nationwide French Study Using Administrative Data Cite
  Lailler G, Memoli V, Le Bihan Benjamin C, Ben Diane M, Lauzier S, Mancini J, et al. Five-Year Adjuvant Endocrine Therapy Adherence Trajectories Among Women With Breast Cancer: A Nationwide French Study Using Administrative Data. Clinical Breast Cancer. Elsevier BV; 2021; 10.1016/j.clbc.2021.01.007
• Bridging the age gap in breast cancer: impact of omission of breast cancer surgery in older women with oestrogen receptor-positive early breast cancer on quality-of-life outcomes Cite
  Morgan JL, Shrestha A, Reed MWR, Herbert E, Bradburn M, Walters SJ, et al. Bridging the age gap in breast cancer: impact of omission of breast cancer surgery in older women with oestrogen receptor-positive early breast cancer on quality-of-life outcomes. British Journal of Surgery. Oxford University Press (OUP); 2021; 10.1093/bjs/znaa125
• Positive estrogen receptor status is a poor prognostic factor in node-negative breast cancer Cite
  Jung EJ, Kim J, Kim J, Lee HS, Kwag S, Park J, et al. Positive estrogen receptor status is a poor prognostic factor in node-negative breast cancer. Medicine. Ovid Technologies (Wolters Kluwer Health); 2021; 100:e25000 10.1097/md.0000000000025000
• Treatment patterns and outcomes in older women with early breast cancer: a population-based cohort study in China Cite
  Liu X, Zheng D, Wu Y, Luo C, Fan Y, Zhong X, et al. Treatment patterns and outcomes in older women with early breast cancer: a population-based cohort study in China. BMC Cancer. Springer Science and Business Media LLC; 2021; 21 10.1186/s12885-021-07947-w
• Long-term outcome and axillary recurrence in elderly women (≥70 years) with breast cancer: 10-years follow-up from a matched cohort study Cite
  Corso G, Magnoni F, Montagna G, Maisonneuve P, Polizzi A, Massari G, et al. Long-term outcome and axillary recurrence in elderly women (≥70 years) with breast cancer: 10-years follow-up from a matched cohort study. European Journal of Surgical Oncology. Elsevier BV; 2021; 10.1016/j.ejso.2021.02.027
• Molecular analyses of triple-negative breast cancer in the young and elderly Cite
  Aine M, Boyaci C, Hartman J, Häkkinen J, Mitra S, Campos AB, et al. Molecular analyses of triple-negative breast cancer in the young and elderly. Breast Cancer Research. Springer Science and Business Media LLC; 2021; 23 10.1186/s13058-021-01392-0
• Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers Cite
  Stjepanovic N, Lubinski J, Moller P, Randall Armel S, Foulkes WD, Tung N, et al. Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-020-06072-9
• Postoperative Survival of Breast Cancer Patients Aged 85 Years or Older: A Retrospective Study Cite
  Enomoto K, Fukumoto S, Hara K, Mori S, Hara Y, Tada K. Postoperative Survival of Breast Cancer Patients Aged 85 Years or Older: A Retrospective Study. Research Square; 2021; 10.21203/rs.3.rs-141173/v1
• Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer Cite
  Wei M, Wang X, Zimmerman DN, Burt LM, Haaland B, Henry NL. Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-020-06071-w
• A population-based study of treatment patterns, 10-year recurrence and breast cancer-specific mortality in a cohort of elderly patients with breast cancer Cite
  Samman S, Cornacchi SD, Foster G, Thabane L, Thomson S, Lovrics O, et al. A population-based study of treatment patterns, 10-year recurrence and breast cancer-specific mortality in a cohort of elderly patients with breast cancer. The American Journal of Surgery. Elsevier BV; 2020; 10.1016/j.amjsurg.2020.12.029
• Persistent taxane‐induced neuropathy in elderly patients treated for localized breast cancer Cite
  Pabst L, Velten M, Fischbach C, Kalish M, Pflumio C, Pivot X, et al. Persistent taxane‐induced neuropathy in elderly patients treated for localized breast cancer. The Breast Journal. Wiley; 2020; 26:2376-2382 10.1111/tbj.14123
• Comorbidity burden in long‐term breast cancer survivors compared with a cohort of population‐based controls from the MARIE study Cite
  Möhl A, Orban E, Jung AY, Behrens S, Obi N, Chang‐Claude J, et al. Comorbidity burden in long‐term breast cancer survivors compared with a cohort of population‐based controls from the MARIE study. Cancer. Wiley; 2020; 10.1002/cncr.33363
• Adjuvant chemotherapy and survival in women aged 70 years and older with triple-negative breast cancer: a Swedish population-based propensity score-matched analysis Cite
  Janeva S, Zhang C, Kovács A, Parris TZ, Crozier JA, Pezzi CM, et al. Adjuvant chemotherapy and survival in women aged 70 years and older with triple-negative breast cancer: a Swedish population-based propensity score-matched analysis. The Lancet Healthy Longevity. Elsevier BV; 2020; 1:e117-e124 10.1016/s2666-7568(20)30018-0
• Addition of chemotherapy to local therapy in women aged 70 years or older with triple-negative breast cancer: a propensity-matched analysis Cite
  Crozier JA, Pezzi TA, Hodge C, Janeva S, Lesnikoski B, Samiian L, et al. Addition of chemotherapy to local therapy in women aged 70 years or older with triple-negative breast cancer: a propensity-matched analysis. The Lancet Oncology. Elsevier BV; 2020; 21:1611-1619 10.1016/s1470-2045(20)30538-6
• The influence of age, comorbidity and frailty on treatment with surgery and systemic therapy in older women with operable triple negative breast cancer (TNBC) in England: A population-based cohort study Cite
  Jauhari Y, Dodwell D, Gannon MR, Horgan K, Clements K, Medina J, et al. The influence of age, comorbidity and frailty on treatment with surgery and systemic therapy in older women with operable triple negative breast cancer (TNBC) in England: A population-based cohort study. European Journal of Surgical Oncology. Elsevier BV; 2020; 10.1016/j.ejso.2020.09.022
• Patient‐reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer Cite
  Nyrop KA, Deal AM, Chen YT, Reeve BB, Basch EM, Wood WA, et al. Patient‐reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer. Cancer. Wiley; 2020; 10.1002/cncr.33329
• Trends in Positive BRCA Test Results Among Older Women in the United States, 2008-2018 Cite
  Guo F, Scholl M, Fuchs EL, Wong R, Kuo Y, Berenson AB. Trends in Positive BRCA Test Results Among Older Women in the United States, 2008-2018. JAMA Network Open. American Medical Association (AMA); 2020; 3:e2024358 10.1001/jamanetworkopen.2020.24358
• A medicare-based comparative mortality analysis of active surveillance in older women with DCIS Cite
  Akushevich I, Yashkin AP, Greenup RA, Hwang ES. A medicare-based comparative mortality analysis of active surveillance in older women with DCIS. npj Breast Cancer. Springer Science and Business Media LLC; 2020; 6 10.1038/s41523-020-00199-0
• Time for BRCA Testing Among Women 65 Years or Older in the United States Cite
  Burton RC. Time for BRCA Testing Among Women 65 Years or Older in the United States. JAMA Network Open. American Medical Association (AMA); 2020; 3:e2024921 10.1001/jamanetworkopen.2020.24921
• Effect of radiotherapy after breast-conserving surgery in elderly patients with early breast cancer according to the AJCC 8th Edition Breast Cancer Staging System in Japan Cite
  Tang L, Ma Z, Ishikawa Y, Matsushita H, Ishida T, Jingu K. Effect of radiotherapy after breast-conserving surgery in elderly patients with early breast cancer according to the AJCC 8th Edition Breast Cancer Staging System in Japan. Breast Cancer. Springer Science and Business Media LLC; 2020; 10.1007/s12282-020-01181-1
• Breast cancer in the oldest old (≥ 89 years): Tumor characteristics, treatment choices, clinical outcomes and literature review Cite
  Di Lascio S, Tognazzo E, Bigiotti S, Bonollo M, Costa A, Pagani O, et al. Breast cancer in the oldest old (≥ 89 years): Tumor characteristics, treatment choices, clinical outcomes and literature review. European Journal of Surgical Oncology. Elsevier BV; 2020; 10.1016/j.ejso.2020.10.008
• Effectiveness of Population-Based Service Screening with Mammography for Women Aged 70–74 Years in Sweden Cite
  Mao Z, Nyström L, Jonsson H. Effectiveness of Population-Based Service Screening with Mammography for Women Aged 70–74 Years in Sweden. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2020; 29:2149-2156 10.1158/1055-9965.epi-20-0523
• The Role of Radiation Therapy in Addition to Lumpectomy and Hormone Therapy in Men 70 Years of Age and Older with Early Breast Cancer: A NCDB Analysis Cite
  Bateni SB, Perry LM, Zhao X, Arora M, Daly ME, Stewart SL, et al. The Role of Radiation Therapy in Addition to Lumpectomy and Hormone Therapy in Men 70 Years of Age and Older with Early Breast Cancer: A NCDB Analysis. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2020; 10.1245/s10434-020-09242-7
• Randomized phase II study of a home-based walking intervention for radiation-related fatigue among older adult breast cancer patients Cite
  VanderWalde NA, Martin MY, Kocak M, Morningstar C, Deal AM, Nyrop KA, et al. Randomized phase II study of a home-based walking intervention for radiation-related fatigue among older adult breast cancer patients. Journal of Geriatric Oncology. Elsevier BV; 2020; 10.1016/j.jgo.2020.09.013
• Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients Cite
  Sawaki M, Taira N, Uemura Y, Saito T, Baba S, Kobayashi K, et al. Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2020; 38:3743-3752 10.1200/jco.20.00184
• Survival Outcomes of Early-Stage Hormone Receptor-Positive Breast Cancer in Elderly Women Cite
  Nayyar A, Strassle PD, Iles K, Jameison D, Jadi J, McGuire KP, et al. Survival Outcomes of Early-Stage Hormone Receptor-Positive Breast Cancer in Elderly Women. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2020; 27:4853-4860 10.1245/s10434-020-08945-1
• Adjuvant breast radiotherapy, endocrine therapy, or both after breast conserving surgery in older women with low-risk breast cancer: Results from a population-based study Cite
  Joseph K, Zebak S, Alba V, Mah K, Au C, Vos L, et al. Adjuvant breast radiotherapy, endocrine therapy, or both after breast conserving surgery in older women with low-risk breast cancer: Results from a population-based study. Radiotherapy and Oncology. Elsevier BV; 2020; 154:93-100 10.1016/j.radonc.2020.09.017
• Radiotherapy after breast‐conserving surgery for elderly patients with early‐stage breast cancer: A national registry‐based study Cite
  Wang F, Meszoely I, Pal T, Mayer IA, Bailey CE, Zheng W, et al. Radiotherapy after breast‐conserving surgery for elderly patients with early‐stage breast cancer: A national registry‐based study. International Journal of Cancer. Wiley; 2020; 148:857-867 10.1002/ijc.33265
• Side effects of adjuvant chemotherapy and their impact on outcome in elderly breast cancer patients: a cohort study Cite
  Zanuso V, Fregoni V, Gervaso L. Side effects of adjuvant chemotherapy and their impact on outcome in elderly breast cancer patients: a cohort study. Future Science OA. Future Science Ltd; 2020;:FSO617 10.2144/fsoa-2020-0076
• Effect of aspirin on cancer incidence and mortality in older adults Cite
  McNeil JJ, Gibbs P, Orchard SG, Lockery JE, Bernstein WB, Cao Y, et al. Effect of aspirin on cancer incidence and mortality in older adults. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2020; 10.1093/jnci/djaa114
• The effect of omission of adjuvant radiotherapy after neoadjuvant chemotherapy and breast conserving surgery with a pathologic complete response Cite
  Mandish SF, Gaskins JT, Yusuf MB, Amer YM, Eldredge-Hindy H. The effect of omission of adjuvant radiotherapy after neoadjuvant chemotherapy and breast conserving surgery with a pathologic complete response. Acta Oncologica. Informa UK Limited; 2020; 59:1210-1217 10.1080/0284186x.2020.1797161
• The Influence of Histologic Grade on Outcomes of Elderly Women With Early Stage Breast Cancer Treated With Breast Conserving Surgery With or Without Radiotherapy Cite
  Escott CE, Zaenger D, Switchencko JM, Lin JY, Abugideiri M, Arciero CA, et al. The Influence of Histologic Grade on Outcomes of Elderly Women With Early Stage Breast Cancer Treated With Breast Conserving Surgery With or Without Radiotherapy. Clinical Breast Cancer. Elsevier BV; 2020; 20:e701-e710 10.1016/j.clbc.2020.05.007
• Association of Chemotherapy With Survival in Elderly Patients With Multiple Comorbidities and Estrogen Receptor–Positive, Node-Positive Breast Cancer Cite
  Tamirisa N, Lin H, Shen Y, Shaitelman SF, Sri Karuturi M, Giordano SH, et al. Association of Chemotherapy With Survival in Elderly Patients With Multiple Comorbidities and Estrogen Receptor–Positive, Node-Positive Breast Cancer. JAMA Oncology. American Medical Association (AMA); 2020; 6:1548 10.1001/jamaoncol.2020.2388
• Is it Wise to Omit Sentinel Node Biopsy in Elderly Patients with Breast Cancer? Cite
  Sun J, Mathias BJ, Sun W, Fulp WJ, Zhou J, Laronga C, et al. Is it Wise to Omit Sentinel Node Biopsy in Elderly Patients with Breast Cancer?. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2020; 28:320-329 10.1245/s10434-020-08759-1
• Survival in older women with early stage breast cancer receiving low‐dose bisphosphonates or denosumab Cite
  Suarez‐Almazor ME, Herrera R, Lei X, Chavez‐MacGregor M, Zhao H, Giordano SH. Survival in older women with early stage breast cancer receiving low‐dose bisphosphonates or denosumab. Cancer. Wiley; 2020; 126:3929-3938 10.1002/cncr.33035
• The association between antidepressants use and development of cognitive impairment among older women diagnosed with breast cancer Cite
  Alatawi Y, Hansen RA, Chou C, Qian J, Suppiramaniam V, Cao G. The association between antidepressants use and development of cognitive impairment among older women diagnosed with breast cancer. European Geriatric Medicine. Springer Science and Business Media LLC; 2020; 11:1017-1026 10.1007/s41999-020-00349-4
• A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns Cite
  Tzikas A, Nemes S, Linderholm BK. A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 182:643-654 10.1007/s10549-020-05727-x
• Radiation and/or endocrine therapy? Recurrence and survival outcomes in women over 70 with early breast cancer after breast-conserving surgery Cite
  Dahn H, Wilke D, Walsh G, Pignol J. Radiation and/or endocrine therapy? Recurrence and survival outcomes in women over 70 with early breast cancer after breast-conserving surgery. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 182:411-420 10.1007/s10549-020-05691-6
• Outcomes of primary endocrine therapy in elderly women with stage I–III breast cancer: a SEER database analysis Cite
  Yuan C, Xie Z, Bian J, Huo J, Daily K. Outcomes of primary endocrine therapy in elderly women with stage I–III breast cancer: a SEER database analysis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 180:819-827 10.1007/s10549-020-05591-9
• Age-related differences in breast cancer mortality according to race/ethnicity, insurance, and socioeconomic status Cite
  San Miguel Y, Gomez SL, Murphy JD, Schwab RB, McDaniels-Davidson C, Canchola AJ, et al. Age-related differences in breast cancer mortality according to race/ethnicity, insurance, and socioeconomic status. BMC Cancer. Springer Science and Business Media LLC; 2020; 20 10.1186/s12885-020-6696-8
• Nodal positivity decreases with age in women with early‐stage, hormone receptor–positive breast cancer Cite
  Downs‐Canner SM, Gaber CE, Louie RJ, Strassle PD, Gallagher KK, Muss HB, et al. Nodal positivity decreases with age in women with early‐stage, hormone receptor–positive breast cancer. Cancer. Wiley; 2019; 126:1193-1201 10.1002/cncr.32668
• Continuation of Annual Screening Mammography and Breast Cancer Mortality in Women Older Than 70 Years Cite
  García-Albéniz X, Hernán MA, Logan RW, Price M, Armstrong K, Hsu J. Continuation of Annual Screening Mammography and Breast Cancer Mortality in Women Older Than 70 Years. Annals of Internal Medicine. American College of Physicians; 2020; 172:381 10.7326/m18-1199
• Simulation of Chemotherapy Effects in Older Breast Cancer Patients With High Recurrence Scores Cite
  Chandler Y, Jayasekera JC, Schechter CB, Isaacs C, Cadham CJ, Mandelblatt JS. Simulation of Chemotherapy Effects in Older Breast Cancer Patients With High Recurrence Scores. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2019; 112:574-581 10.1093/jnci/djz189
• Radiotherapy Utilization for Patients Over Age 60 With Early Stage Breast Cancer Cite
  Paulsson AK, Fowble B, Lazar AA, Park C, Sherertz T. Radiotherapy Utilization for Patients Over Age 60 With Early Stage Breast Cancer. Clinical Breast Cancer. Elsevier BV; 2020; 20:168-173 10.1016/j.clbc.2019.10.005
• Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century Cite
  Yadav S, Karam D, Bin Riaz I, Xie H, Durani U, Duma N, et al. Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century. Cancer. Wiley; 2019; 126:26-36 10.1002/cncr.32472
• Characteristics of adverse events of endocrine therapies among older patients with breast cancer Cite
  Honma N, Makita M, Saji S, Mikami T, Ogata H, Horii R, et al. Characteristics of adverse events of endocrine therapies among older patients with breast cancer. Supportive Care in Cancer. Society for Mining, Metallurgy and Exploration Inc.; 2019; 27:3813-3822 10.1007/s00520-019-04674-8
• Screening Mammography Outcomes: Risk of Breast Cancer and Mortality by Comorbidity Score and Age Cite
  Demb J, Abraham L, Miglioretti DL, Sprague BL, O’Meara ES, Advani S, et al. Screening Mammography Outcomes: Risk of Breast Cancer and Mortality by Comorbidity Score and Age. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2019; 112:599-606 10.1093/jnci/djz172
• Breast-conserving surgery without radiation in elderly women with early breast cancer Cite
  Inoue H, Hirano A, Ogura K, Kamimura M, Hattori A, Yukawa H, et al. Breast-conserving surgery without radiation in elderly women with early breast cancer. Surgical Oncology. Elsevier BV; 2019; 31:22-25 10.1016/j.suronc.2019.08.008
• Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor–Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database Cite
  Buszek SM, Lin HY, Bedrosian I, Tamirisa N, Babiera GV, Shen Y, et al. Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor–Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2019; 105:795-802 10.1016/j.ijrobp.2019.07.052
• Radiation Therapy After Breast-Conserving Surgery in Women 70 Years of Age and Older: How Wisely Do We Choose? Cite
  Downs-Canner S, Zabor EC, Wind T, Cobovic A, McCormick B, Morrow M, et al. Radiation Therapy After Breast-Conserving Surgery in Women 70 Years of Age and Older: How Wisely Do We Choose?. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2019; 26:969-975 10.1245/s10434-018-07151-4
• Oncologic Results of Breast Conserving Surgery under Procedural Sedation in Elderly Patients Cite
  Lee J, Jung JH, Kim WW, Lim YS, Lee RK, Kwak K, et al. Oncologic Results of Breast Conserving Surgery under Procedural Sedation in Elderly Patients. Journal of Breast Disease. Korean Breast Cancer Society; 2019; 7:9-15 10.14449/jbd.2019.7.1.9
• Targeted therapy for breast cancer in older patients Cite
  Pondé N, Wildiers H, Awada A, de Azambuja E, Deliens C, Lago LD. Targeted therapy for breast cancer in older patients. Journal of Geriatric Oncology. Elsevier BV; 2020; 11:380-388 10.1016/j.jgo.2019.05.012
• Bisphosphonate use in geriatric breast cancer patients on aromatase inhibitors in a rural population. Cite
  Johnson A, Agbisit C, Robinson K, Delfino K, Desai MR. Bisphosphonate use in geriatric breast cancer patients on aromatase inhibitors in a rural population.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2019; 37:e12048-e12048 10.1200/jco.2019.37.15_suppl.e12048
• Super-elderly patient-specific perioperative complications in breast cancer surgery Cite
  Ogawa Y, Ikeda K, Watanabe C, Kamei Y, Goto W, Shiraishi C, et al. Super-elderly patient-specific perioperative complications in breast cancer surgery. Surgery Today. Springer Science and Business Media LLC; 2019; 49:843-849 10.1007/s00595-019-01812-x
• The Impact of Age and Adjuvant Chemotherapy Modifications on Survival Among Black Women With Breast Cancer Cite
  Nugent BD, Ren D, Bender CM, Rosenzweig M. The Impact of Age and Adjuvant Chemotherapy Modifications on Survival Among Black Women With Breast Cancer. Clinical Breast Cancer. Elsevier BV; 2019; 19:254-258 10.1016/j.clbc.2019.02.012
• Long-term decision regret surrounding systemic therapy in older breast cancer survivors: A population-based survey study Cite
  Karuturi MS, Lei X, Shen Y, Giordano SH, Swanick CW, Smith BD. Long-term decision regret surrounding systemic therapy in older breast cancer survivors: A population-based survey study. Journal of Geriatric Oncology. Elsevier BV; 2019; 10:973-979 10.1016/j.jgo.2019.03.013
• Association between cognitive impairment and guideline adherence for application of chemotherapy in older patients with breast cancer: Results from the prospective multicenter BRENDA II study Cite
  Leinert E, Schwentner L, Blettner M, Wöckel A, Felberbaum R, Flock F, et al. Association between cognitive impairment and guideline adherence for application of chemotherapy in older patients with breast cancer: Results from the prospective multicenter BRENDA II study. The Breast Journal. Wiley; 2019; 25:386-392 10.1111/tbj.13231
• Treatment Patterns and Mortality Risk among Elderly Patients with Metastatic Triple Negative Breast Cancer in the United States: An Observational Cohort Study Using SEER-Medicare Data Cite
  Satram-Hoang S, Bajaj P, Stein A, Cortazar P, Momin F, Reyes C. Treatment Patterns and Mortality Risk among Elderly Patients with Metastatic Triple Negative Breast Cancer in the United States: An Observational Cohort Study Using SEER-Medicare Data. Journal of Cancer Therapy. Scientific Research Publishing, Inc.; 2019; 10:117-133 10.4236/jct.2019.102009
• Abstract P1-11-21: Analysis of cognitive function in elderly HER2-positive breast cancer patients receiving either trastuzumab monotherapy or trastuzumab plus chemotherapy as a postoperative adjuvant treatment: A cognitive function sub-study of a randomized, open-label, phase 3 clinical trial (RESPECT trial) Cite
  Takahashi M, Sawaki M, Hagiwara Y, Uemura Y, Kawahara T, Shimozuma K, et al. Abstract P1-11-21: Analysis of cognitive function in elderly HER2-positive breast cancer patients receiving either trastuzumab monotherapy or trastuzumab plus chemotherapy as a postoperative adjuvant treatment: A cognitive function sub-study of a randomized, open-label, phase 3 clinical trial (RESPECT trial). Poster Session Abstracts. American Association for Cancer Research; 2019; 10.1158/1538-7445.sabcs18-p1-11-21
• Surgical treatment and prognosis of breast cancer in elderly – A population-based study Cite
  Ojala K, Meretoja TJ, Mattson J, Leidenius MH. Surgical treatment and prognosis of breast cancer in elderly – A population-based study. European Journal of Surgical Oncology. Elsevier BV; 2019; 45:956-962 10.1016/j.ejso.2019.01.019
• The role of post‐mastectomy radiotherapy in elderly patients with 1‐3 positive lymph nodes breast cancer: An International Retrospective Double‐Center Study Cite
  Cao L, G. Adedjouma N, Xu C, Shen K, Laki F, Chen J, et al. The role of post‐mastectomy radiotherapy in elderly patients with 1‐3 positive lymph nodes breast cancer: An International Retrospective Double‐Center Study. The Breast Journal. Wiley; 2019; 25:107-111 10.1111/tbj.13163
• The Optimal Adjuvant Treatment in Older Patients with Hormone Receptor Positive Early Stage Breast Cancer (BC) is Breast Radiation (RT) not Endocrine Therapy (ET) Cite
  Chadha M, Shao T, Klein P, Malamud S, Cate S, White C, et al. The Optimal Adjuvant Treatment in Older Patients with Hormone Receptor Positive Early Stage Breast Cancer (BC) is Breast Radiation (RT) not Endocrine Therapy (ET). International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2018; 102:e582 10.1016/j.ijrobp.2018.07.1605
• Long-term Subsequent Breast Cancer Risk and Overall Survival in Older Women with Estrogen Receptor Positive Early Stage Breast Cancer Treated in a Community Health Plan Cite
  Jiang D, Chen J, Xu X, Tian Y, Avila C, Haque R. Long-term Subsequent Breast Cancer Risk and Overall Survival in Older Women with Estrogen Receptor Positive Early Stage Breast Cancer Treated in a Community Health Plan. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2018; 102:e586-e587 10.1016/j.ijrobp.2018.07.1615
• Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer Cite
  Minicozzi P, Van Eycken L, Molinie F, Innos K, Guevara M, Marcos-Gragera R, et al. Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer. International Journal of Cancer. Wiley; 2018; 144:2118-2127 10.1002/ijc.31974
• Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study Cite
  Mandelblatt JS, Small BJ, Luta G, Hurria A, Jim H, McDonald BC, et al. Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018; 36:3211-3222 10.1200/jco.18.00140
• Radiation Therapy for Positive Surgical Margins in Women ≥70 Years with Stage I, Estrogen Receptor-positive Breast Cancer Cite
  ZHOU M, PEDDI P, CHU QD. Radiation Therapy for Positive Surgical Margins in Women ≥70 Years with Stage I, Estrogen Receptor-positive Breast Cancer. Anticancer Research. Anticancer Research USA Inc.; 2018; 38:5253-5260 10.21873/anticanres.12850
• Patients electing to have PET rather than surgery for operable breast cancer are a high risk of treatment failure Cite
  Thomas R, Rowell R, Crichton S, Cain H. Patients electing to have PET rather than surgery for operable breast cancer are a high risk of treatment failure. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 172:597-601 10.1007/s10549-018-4943-3
• Functional Status and Survival After Breast Cancer Surgery in Nursing Home Residents Cite
  Tang V, Zhao S, Boscardin J, Sudore R, Covinsky K, Walter LC, et al. Functional Status and Survival After Breast Cancer Surgery in Nursing Home Residents. JAMA Surgery. American Medical Association (AMA); 2018; 153:1090 10.1001/jamasurg.2018.2736
• The rationale for and long-term outcome of incomplete axillary staging in elderly women with primary breast cancer Cite
  Poodt IG, Schipper R, Vugts G, Woensdregt K, van der Sangen M, Voogd AC, et al. The rationale for and long-term outcome of incomplete axillary staging in elderly women with primary breast cancer. European Journal of Surgical Oncology. Elsevier BV; 2018; 44:1714-1719 10.1016/j.ejso.2018.07.005
• Axillary Nodal Evaluation in Elderly Breast Cancer Patients: Potential Effects on Treatment Decisions and Survival Cite
  Tamirisa N, Thomas SM, Fayanju OM, Greenup RA, Rosenberger LH, Hyslop T, et al. Axillary Nodal Evaluation in Elderly Breast Cancer Patients: Potential Effects on Treatment Decisions and Survival. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2018; 25:2890-2898 10.1245/s10434-018-6595-2
• Cognitive Changes After Adjuvant Treatment in Older Adults with Early‐Stage Breast Cancer Cite
  Lange M, Heutte N, Noal S, Rigal O, Kurtz J, Lévy C, et al. Cognitive Changes After Adjuvant Treatment in Older Adults with Early‐Stage Breast Cancer. The Oncologist. Wiley; 2018; 24:62-68 10.1634/theoncologist.2017-0570
• Adjuvant Radiation Therapy for T3N0 Breast Cancer Patients Older Than 75 Years After Mastectomy: A SEER Analysis Cite
  Chen J, Wu X, Christos P, Yan W, Ravi A. Adjuvant Radiation Therapy for T3N0 Breast Cancer Patients Older Than 75 Years After Mastectomy: A SEER Analysis. Clinical Breast Cancer. Elsevier BV; 2018; 18:e967-e973 10.1016/j.clbc.2018.05.002
• Omission of surgery in older women with early breast cancer has an adverse impact on breast cancer-specific survival Cite
  Ward SE, Richards PD, Morgan JL, Holmes GR, Broggio JW, Collins K, et al. Omission of surgery in older women with early breast cancer has an adverse impact on breast cancer-specific survival. British Journal of Surgery. Wiley; 2018; 105:1454-1463 10.1002/bjs.10885
• Receipt of Guideline-Concordant Care Among Older Women With Stage I–III Breast Cancer: A Population-Based Study Cite
  LeMasters T, Madhavan SS, Sambamoorthi U, Hazard-Jenkins HW, Kelly KM, Long D. Receipt of Guideline-Concordant Care Among Older Women With Stage I–III Breast Cancer: A Population-Based Study. Journal of the National Comprehensive Cancer Network. Harborside Press, LLC; 2018; 16:703-710 10.6004/jnccn.2018.7004
• Variation in treatment and survival of older patients with non-metastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group Cite
  Derks MGM, Bastiaannet E, Kiderlen M, Hilling DE, Boelens PG, Walsh PM, et al. Variation in treatment and survival of older patients with non-metastatic breast cancer in five European countries: a population-based cohort study from the EURECCA Breast Cancer Group. British Journal of Cancer. Springer Science and Business Media LLC; 2018; 119:121-129 10.1038/s41416-018-0090-1
• The relationship between patient and tumor characteristics, patterns of breast cancer care, and 5-year survival among elderly women with incident breast cancer Cite
  Kong AL, Nattinger AB, McGinley E, Pezzin LE. The relationship between patient and tumor characteristics, patterns of breast cancer care, and 5-year survival among elderly women with incident breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2018; 171:477-488 10.1007/s10549-018-4837-4
• Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe Cite
  Wickberg Å, Liljegren G, Killander F, Lindman H, Bjöhle J, Carlberg M, et al. Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe. European Journal of Surgical Oncology. Elsevier BV; 2018; 44:951-956 10.1016/j.ejso.2018.04.002
• Breast cancer in octogenarian. Are we doing our best? A population-registry based study Cite
  Martinez-Ramos D, Simon-Monterde L, Queralt-Martin R, Suelves-Piqueres C, Menor-Duran P, Escrig-Sos J. Breast cancer in octogenarian. Are we doing our best? A population-registry based study. The Breast. Elsevier BV; 2018; 38:81-85 10.1016/j.breast.2017.12.007
• Multiple primary non-breast tumors in breast cancer survivors Cite
  Corso G, Veronesi P, Santomauro GI, Maisonneuve P, Morigi C, Peruzzotti G, et al. Multiple primary non-breast tumors in breast cancer survivors. Journal of Cancer Research and Clinical Oncology. Springer Science and Business Media LLC; 2018; 144:979-986 10.1007/s00432-018-2621-9
• Breast Density and Risk of Invasive Breast Cancer among Older Women Undergoing Mammography: The Breast Cancer Surveillance Consortium Cohort Study Cite
  Braithwaite D, Miglioretti D, Zhu W, Demb J, Trentham-Dietz A, Sprague B, et al. Breast Density and Risk of Invasive Breast Cancer among Older Women Undergoing Mammography: The Breast Cancer Surveillance Consortium Cohort Study. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2018; 27:352.2-352 10.1158/1055-9965.epi-18-0044
• Breast cancer-specific survival by age: Worse outcomes for the oldest patients Cite
  Freedman RA, Keating NL, Lin NU, Winer EP, Vaz-Luis I, Lii J, et al. Breast cancer-specific survival by age: Worse outcomes for the oldest patients. Cancer. Wiley; 2018; 124:2184-2191 10.1002/cncr.31308
• Management of positive margins after initial lumpectomy in elderly women with breast cancer Cite
  Angarita FA, Acuna SA, McCready DR, Escallon J. Management of positive margins after initial lumpectomy in elderly women with breast cancer. European Journal of Surgical Oncology. Elsevier BV; 2018; 44:1048-1053 10.1016/j.ejso.2018.02.011
• Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort Cite
  Braithwaite D, Miglioretti DL, Zhu W, Demb J, Trentham-Dietz A, Sprague B, et al. Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort. JAMA Internal Medicine. American Medical Association (AMA); 2018; 178:494 10.1001/jamainternmed.2017.8642
• Direct-to-Implant Breast Reconstruction in Women Older than 65 Years Cite
  Knackstedt R, Gatherwright J, Moreira A. Direct-to-Implant Breast Reconstruction in Women Older than 65 Years. Plastic and Reconstructive Surgery. Ovid Technologies (Wolters Kluwer Health); 2018; 141:251-256 10.1097/prs.0000000000004015
• Treatment Strategies in Octogenarians with Early-Stage, High-Risk Breast Cancer Cite
  Mamtani A, Gonzalez JJ, Neo DT, Friedman RS, Recht A, Hacker MR, et al. Treatment Strategies in Octogenarians with Early-Stage, High-Risk Breast Cancer. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2018; 25:1495-1501 10.1245/s10434-018-6350-8
• Oestrogen receptor negative early operable primary breast cancer in older women—Biological characteristics and long-term clinical outcome Cite
  Syed BM, Morgan D, Setty T, Green AR, Paish EC, Ellis IO, et al. Oestrogen receptor negative early operable primary breast cancer in older women—Biological characteristics and long-term clinical outcome. PLOS ONE. Public Library of Science (PLoS); 2017; 12:e0188528 10.1371/journal.pone.0188528
• Routine treatment and outcome of breast cancer in younger versus elderly patients: results from the SENORA project of the prospective German TMK cohort study Cite
  Fietz T, Zahn M, Köhler A, Engel E, Frank M, Kruggel L, et al. Routine treatment and outcome of breast cancer in younger versus elderly patients: results from the SENORA project of the prospective German TMK cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 167:567-578 10.1007/s10549-017-4534-8
• Diabetes Treatments and Risks of Adverse Breast Cancer Outcomes among Early-Stage Breast Cancer Patients: A SEER-Medicare Analysis Cite
  Chen L, Chubak J, Boudreau DM, Barlow WE, Weiss NS, Li CI. Diabetes Treatments and Risks of Adverse Breast Cancer Outcomes among Early-Stage Breast Cancer Patients: A SEER-Medicare Analysis. Cancer Research. American Association for Cancer Research (AACR); 2017; 77:6033-6041 10.1158/0008-5472.can-17-0687
• An observational study investigating failure of primary endocrine therapy for operable breast cancer in the elderly Cite
  Thomas R, Rowell R, Crichton S, Cain H. An observational study investigating failure of primary endocrine therapy for operable breast cancer in the elderly. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 167:73-80 10.1007/s10549-017-4494-z
• Breast cancer in elderly women and altered clinico-pathological characteristics: a systematic review Cite
  Lodi M, Scheer L, Reix N, Heitz D, Carin A, Thiébaut N, et al. Breast cancer in elderly women and altered clinico-pathological characteristics: a systematic review. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 166:657-668 10.1007/s10549-017-4448-5
• Comprehensive geriatric assessment in 326 older women with early breast cancer Cite
  Okonji DO, Sinha R, Phillips I, Fatz D, Ring A. Comprehensive geriatric assessment in 326 older women with early breast cancer. British Journal of Cancer. Springer Science and Business Media LLC; 2017; 117:925-931 10.1038/bjc.2017.257
• The footprint of the ageing stroma in older patients with breast cancer Cite
  Brouwers B, Fumagalli D, Brohee S, Hatse S, Govaere O, Floris G, et al. The footprint of the ageing stroma in older patients with breast cancer. Breast Cancer Research. Springer Science and Business Media LLC; 2017; 19 10.1186/s13058-017-0871-0
• Radiation therapy utilization and outcomes for older women with breast cancer: Impact of molecular subtype and tumor grade Cite
  Haque W, Kee Yuan DM, Verma V, Butler EB, Teh BS, Wiederhold L, et al. Radiation therapy utilization and outcomes for older women with breast cancer: Impact of molecular subtype and tumor grade. The Breast. Elsevier BV; 2017; 35:34-41 10.1016/j.breast.2017.06.011
• Mammographic density and ageing: A collaborative pooled analysis of cross-sectional data from 22 countries worldwide Cite
  Burton A, Maskarinec G, Perez-Gomez B, Vachon C, Miao H, Lajous M, et al. Mammographic density and ageing: A collaborative pooled analysis of cross-sectional data from 22 countries worldwide. PLOS Medicine. Public Library of Science (PLoS); 2017; 14:e1002335 10.1371/journal.pmed.1002335
• The Use of Hormone Therapy Alone Versus Hormone Therapy and Radiation Therapy for Breast Cancer in Elderly Women: A Population-Based Study Cite
  Nichol AM, Chan EK, Lucas S, Smith SL, Gondara L, Speers C, et al. The Use of Hormone Therapy Alone Versus Hormone Therapy and Radiation Therapy for Breast Cancer in Elderly Women: A Population-Based Study. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2017; 98:829-839 10.1016/j.ijrobp.2017.02.094
• Triple-negative breast cancer in the elderly: Prognosis and treatment Cite
  Kaplan HG, Malmgren JA, Atwood MK. Triple-negative breast cancer in the elderly: Prognosis and treatment. The Breast Journal. Wiley; 2017; 23:630-637 10.1111/tbj.12813
• Tamoxifen with radiotherapy compared with Tamoxifen alone in elderly women with early-stage breast cancer treated with breast conserving surgery: A systematic review and meta-analysis Cite
  Chesney TR, Yin JX, Rajaee N, Tricco AC, Fyles AW, Acuna SA, et al. Tamoxifen with radiotherapy compared with Tamoxifen alone in elderly women with early-stage breast cancer treated with breast conserving surgery: A systematic review and meta-analysis. Radiotherapy and Oncology. Elsevier BV; 2017; 123:1-9 10.1016/j.radonc.2017.02.019
• Ageism and surgical treatment of breast cancer in Italian hospitals Cite
  Di Rosa M, Chiatti C, Rimland JM, Capasso M, Scandali VM, Prospero E, et al. Ageism and surgical treatment of breast cancer in Italian hospitals. Aging Clinical and Experimental Research. Springer Science and Business Media LLC; 2017; 30:139-144 10.1007/s40520-017-0757-0
• Use of Geriatric Assessment Tools in Selecting Therapies in Women Aged ≥70 Years With Hormone Receptor–Positive Early-Stage Breast Cancer: Preliminary Experience With a Quality Improvement Initiative Cite
  Wright JL, Parekh A, Pollock YY, Schoenborn N, Smith KL, Magnant C, et al. Use of Geriatric Assessment Tools in Selecting Therapies in Women Aged ≥70 Years With Hormone Receptor–Positive Early-Stage Breast Cancer: Preliminary Experience With a Quality Improvement Initiative. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2017; 98:884-890 10.1016/j.ijrobp.2017.01.210
• Age-Specific Indicators of a Healthy Lifestyle and Postmenopausal Breast Cancer Cite
  McClain KM, McCullough LE, Bradshaw PT, Shantakumar S, Terry MB, Neugut AI, et al. Age-Specific Indicators of a Healthy Lifestyle and Postmenopausal Breast Cancer. Journal of Women's Health. Mary Ann Liebert Inc; 2017; 26:1176-1184 10.1089/jwh.2016.6028
• Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance) Cite
  Mandelblatt JS, Cai L, Luta G, Kimmick G, Clapp J, Isaacs C, et al. Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance). Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 164:107-117 10.1007/s10549-017-4222-8
• Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment Cite
  Marshall TF, Zipp GP, Battaglia F, Moss R, Bryan S. Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment. Journal of Cancer Research and Practice. Medknow; 2017; 4:134-138 10.1016/j.jcrpr.2017.03.005
• Breast-Conserving Surgery Under Local Anesthesia in Elderly Patients with Severe Cardiorespiratory Comorbidities: A Hospital-Based Case-Control Study Cite
  Karanlik H, Kılıç B, Yıldırım I, Bademler S, Ozgur I, Ilhan B, et al. Breast-Conserving Surgery Under Local Anesthesia in Elderly Patients with Severe Cardiorespiratory Comorbidities: A Hospital-Based Case-Control Study. Breast Care. S. Karger AG; 2017; 12:28-32 10.1159/000455003
• Short-term, postoperative breast cancer outcomes in patients with advanced age Cite
  Pettke E, Ilonzo N, Ayewah M, Tsantes S, Estabrook A, Ma AMT. Short-term, postoperative breast cancer outcomes in patients with advanced age. The American Journal of Surgery. Elsevier BV; 2016; 212:677-681 10.1016/j.amjsurg.2016.06.007
• Trastuzumab in Human Epidermal Growth Factor Receptor 2‐Positive Early Breast Cancer: Results of a Prospective, Noninterventional Study on Routine Treatment Between 2006 and 2012 in Germany Cite
  Dall P, Koch T, Göhler T, Selbach J, Ammon A, Eggert J, et al. Trastuzumab in Human Epidermal Growth Factor Receptor 2‐Positive Early Breast Cancer: Results of a Prospective, Noninterventional Study on Routine Treatment Between 2006 and 2012 in Germany. The Oncologist. Wiley; 2017; 22:131-138 10.1634/theoncologist.2016-0193
• Postoperative Complications After Breast Cancer Surgery are Not Related to Age Cite
  ten Wolde B, Kuiper M, de Wilt JHW, Strobbe LJA. Postoperative Complications After Breast Cancer Surgery are Not Related to Age. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2017; 24:1861-1867 10.1245/s10434-016-5726-x
• Comparative Effect of Initiating Metformin Versus Sulfonylureas on Breast Cancer Risk in Older Women Cite
  Hong J, Jonsson Funk M, Buse JB, Henderson LM, Lund JL, Pate V, et al. Comparative Effect of Initiating Metformin Versus Sulfonylureas on Breast Cancer Risk in Older Women. Epidemiology. Ovid Technologies (Wolters Kluwer Health); 2017; 28:446-454 10.1097/ede.0000000000000635
• Chemotherapy in Old Women with Breast Cancer: Is Age Still a Predictor for Under Treatment? Cite
  Meresse M, Bouhnik A, Bendiane M, Retornaz F, Rousseau F, Rey D, et al. Chemotherapy in Old Women with Breast Cancer: Is Age Still a Predictor for Under Treatment?. The Breast Journal. Wiley; 2016; 23:256-266 10.1111/tbj.12726
• Adjuvant Radiation Improves Survival in Older Women Following Breast-Conserving Surgery for Estrogen Receptor–Negative Breast Cancer Cite
  Daugherty EC, Daugherty MR, Bogart JA, Shapiro A. Adjuvant Radiation Improves Survival in Older Women Following Breast-Conserving Surgery for Estrogen Receptor–Negative Breast Cancer. Clinical Breast Cancer. Elsevier BV; 2016; 16:500-506.e2 10.1016/j.clbc.2016.06.017
• Omission of axillary staging in elderly patients with early stage breast cancer impacts regional control but not survival: A systematic review and meta-analysis Cite
  Liang S, Hallet J, Simpson JS, Tricco AC, Scheer AS. Omission of axillary staging in elderly patients with early stage breast cancer impacts regional control but not survival: A systematic review and meta-analysis. Journal of Geriatric Oncology. Elsevier BV; 2017; 8:140-147 10.1016/j.jgo.2016.12.003
• Low risk of recurrence in elderly patients treated with breast conserving therapy in a single institute Cite
  van der Leij F, van Werkhoven E, Bosma S, Linn SC, Rutgers EJ, van de Vijver MJ, et al. Low risk of recurrence in elderly patients treated with breast conserving therapy in a single institute. The Breast. Elsevier BV; 2016; 30:19-25 10.1016/j.breast.2016.08.004
• Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database Cite
  Chen H, Zhou M, Tian W, Meng K, He H. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0165409 10.1371/journal.pone.0165409
• Aging, obesity, and post-therapy cognitive recovery in breast cancer survivors Cite
  Huang Z, Zheng Y, Bao P, Cai H, Hong Z, Ding D, et al. Aging, obesity, and post-therapy cognitive recovery in breast cancer survivors. Oncotarget. Impact Journals, LLC; 2016; 8:12364-12373 10.18632/oncotarget.12565
• Long‐term trajectories of self‐reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance) Cite
  Mandelblatt JS, Clapp JD, Luta G, Faul LA, Tallarico MD, McClendon TD, et al. Long‐term trajectories of self‐reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance). Cancer. Wiley; 2016; 122:3555-3563 10.1002/cncr.30208
• Adjuvant Radiation Improves Survival in Older Women Following Breast-Conserving Surgery for Estrogen Receptor–Negative Breast Cancer Cite
  Daugherty EC, Daugherty MR, Bogart JA, Shapiro A. Adjuvant Radiation Improves Survival in Older Women Following Breast-Conserving Surgery for Estrogen Receptor–Negative Breast Cancer. Clinical Breast Cancer. Elsevier BV; 2016; 16:500-506.e2 10.1016/j.clbc.2016.06.017
• Benefit of adjuvant radiotherapy after breast-conserving therapy among elderly women with T1-T2N0 estrogen receptor-negative breast cancer Cite
  Eaton BR, Jiang R, Torres MA, Kahn ST, Godette K, Lash TL, et al. Benefit of adjuvant radiotherapy after breast-conserving therapy among elderly women with T1-T2N0 estrogen receptor-negative breast cancer. Cancer. Wiley; 2016; 122:3059-3068 10.1002/cncr.30142
• The association of age with breast cancer mortality within four race/ethnicities for the triple negative and HER2-overexpressing subtypes. Cite
  Parise C, Caggiano V. The association of age with breast cancer mortality within four race/ethnicities for the triple negative and HER2-overexpressing subtypes.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016; 34:1073-1073 10.1200/jco.2016.34.15_suppl.1073
• Long-term age-dependent failure pattern after breast-conserving therapy or mastectomy among Danish lymph-node-negative breast cancer patients Cite
  Laurberg T, Lyngholm CD, Christiansen P, Alsner J, Overgaard J. Long-term age-dependent failure pattern after breast-conserving therapy or mastectomy among Danish lymph-node-negative breast cancer patients. Radiotherapy and Oncology. Elsevier BV; 2016; 120:98-106 10.1016/j.radonc.2016.05.006
• Short-course radiotherapy in elderly women with breast cancer: Comparison by age, comorbidity index and toxicity Cite
  Giugliano FM, Falivene S, Esposito E, Di Franco R, D'Aiuto M, Lanza F, et al. Short-course radiotherapy in elderly women with breast cancer: Comparison by age, comorbidity index and toxicity. International Journal of Surgery. Elsevier BV; 2016; 33:S92-S96 10.1016/j.ijsu.2016.05.045
• Radiotherapy in Patients 70 Years and Older With Triple-Negative Breast Cancer Cite
  Algan O, Zhao YD, Herman T. Radiotherapy in Patients 70 Years and Older With Triple-Negative Breast Cancer. Clinical Breast Cancer. Elsevier BV; 2016; 16:e99-e106 10.1016/j.clbc.2016.05.011
• Prognostic impact of breast cancer subtypes in elderly patients Cite
  Bergen ES, Tichy C, Berghoff AS, Rudas M, Dubsky P, Bago-Horvath Z, et al. Prognostic impact of breast cancer subtypes in elderly patients. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2016; 157:91-99 10.1007/s10549-016-3787-y
• Breast Cancer in Women Older Than 80 Years Cite
  Shachar SS, Hurria A, Muss HB. Breast Cancer in Women Older Than 80 Years. Journal of Oncology Practice. American Society of Clinical Oncology (ASCO); 2016; 12:123-132 10.1200/jop.2015.010207
• The use of surgery in the treatment of ER+ early stage breast cancer in England: Variation by time, age and patient characteristics Cite
  Richards P, Ward S, Morgan J, Lagord C, Reed M, Collins K, et al. The use of surgery in the treatment of ER+ early stage breast cancer in England: Variation by time, age and patient characteristics. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2016; 42:489-496 10.1016/j.ejso.2015.12.012
• RETRACTED: Impact of Cooperative Trial and Sociodemographic Variation on Adjuvant Radiation Therapy Usage in Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-Positive Breast Cancer: Analysis of the National Cancer Data Base Cite
  Chu QD, Medeiros KL, Zhou M, Peddi P, Wu X. RETRACTED: Impact of Cooperative Trial and Sociodemographic Variation on Adjuvant Radiation Therapy Usage in Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-Positive Breast Cancer: Analysis of the National Cancer Data Base. Journal of the American College of Surgeons. Elsevier BV; 2016; 222:667-678 10.1016/j.jamcollsurg.2015.12.018
• Surgery and hormone therapy trends in octogenarians with invasive breast cancer Cite
  Kantor O, Pesce C, Liederbach E, Wang C, Winchester DJ, Yao K. Surgery and hormone therapy trends in octogenarians with invasive breast cancer. The American Journal of Surgery. Elsevier BV; 2016; 211:541-545 10.1016/j.amjsurg.2015.11.005
• Quality of life in elderly patients with localized breast cancer treated with radiotherapy. A prospective study Cite
  Arraras JI, Manterola A, Asin G, Illarramendi JJ, Cruz Sdl, Ibañez B, et al. Quality of life in elderly patients with localized breast cancer treated with radiotherapy. A prospective study. The Breast. Elsevier BV; 2016; 26:46-53 10.1016/j.breast.2015.12.008
• Mammography Screening Among the Elderly: A Research Challenge Cite
  Sanderson M, Levine RS, Fadden MK, Kilbourne B, Pisu M, Cain V, et al. Mammography Screening Among the Elderly: A Research Challenge. The American Journal of Medicine. Elsevier BV; 2015; 128:1362.e7-1362.e14 10.1016/j.amjmed.2015.06.032
• Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis Cite
  Ryser MD, Worni M, Turner EL, Marks JR, Durrett R, Hwang ES. Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis. Journal of the National Cancer Institute. Oxford University Press (OUP); 2015; 108:djv372 10.1093/jnci/djv372
• The prognostic value of age for invasive lobular breast cancer depending on estrogen receptor and progesterone receptor-defined subtypes: A NCDB analysis Cite
  Liu J, Chen K, Mao K, Su F, Liu Q, Jacobs LK. The prognostic value of age for invasive lobular breast cancer depending on estrogen receptor and progesterone receptor-defined subtypes: A NCDB analysis. Oncotarget. Impact Journals, LLC; 2015; 7:6063-6073 10.18632/oncotarget.5844
• Improvements in US Breast Cancer Survival and Proportion Explained by Tumor Size and Estrogen-Receptor Status Cite
  Park J, Anderson WF, Gail MH. Improvements in US Breast Cancer Survival and Proportion Explained by Tumor Size and Estrogen-Receptor Status. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015; 33:2870-2876 10.1200/jco.2014.59.9191
• Age-dependency in the metabolism of flaxseed lignans by healthy adults Cite
  Edel AL, Pierce GN, Aliani M. Age-dependency in the metabolism of flaxseed lignans by healthy adults. Journal of Functional Foods. Elsevier BV; 2015; 17:948-957 10.1016/j.jff.2015.06.042
• Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer Registries Cite
  Zhu W, Perez EA, Hong R, Li Q, Xu B. Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer Registries. PLOS ONE. Public Library of Science (PLoS); 2015; 10:e0128345 10.1371/journal.pone.0128345
• Omission of radiotherapy in elderly patients with early breast cancer: 15-Year results of a prospective non-randomised trial Cite
  Martelli G, Boracchi P, Guzzetti E, Marano G, Lozza L, Agresti R, et al. Omission of radiotherapy in elderly patients with early breast cancer: 15-Year results of a prospective non-randomised trial. European Journal of Cancer. Elsevier BV; 2015; 51:1358-1364 10.1016/j.ejca.2015.04.018
• Benefits and Harms of Mammography Screening After Age 74 Years: Model Estimates of Overdiagnosis Cite
  van Ravesteyn NT, Stout NK, Schechter CB, Heijnsdijk EAM, Alagoz O, Trentham-Dietz A, et al. Benefits and Harms of Mammography Screening After Age 74 Years: Model Estimates of Overdiagnosis. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2015; 107:djv103-djv103 10.1093/jnci/djv103
• Effect of age on drug metabolism in women with breast cancer Cite
  Singh JC, Lichtman SM. Effect of age on drug metabolism in women with breast cancer. Expert Opinion on Drug Metabolism & Toxicology. Informa Healthcare; 2015; 11:757-766 10.1517/17425255.2015.1037277
• Aggressive Intrinsic Subtypes in Breast Cancer: A Predictor of Guideline Adherence in Older Patients With Breast Cancer? Cite
  Ebner F, Hancke K, Blettner M, Schwentner L, Wöckel A, Kreienberg R, et al. Aggressive Intrinsic Subtypes in Breast Cancer: A Predictor of Guideline Adherence in Older Patients With Breast Cancer?. Clinical Breast Cancer. Elsevier BV; 2015; 15:e189-e195 10.1016/j.clbc.2015.03.003
• Comparison of Adjuvant Radiation Therapy Alone Versus Radiation Therapy and Endocrine Therapy in Elderly Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Treated With Breast-Conserving Surgery Cite
  Murphy CT, Li T, Wang LS, Obeid EI, Bleicher RJ, Eastwick G, et al. Comparison of Adjuvant Radiation Therapy Alone Versus Radiation Therapy and Endocrine Therapy in Elderly Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Treated With Breast-Conserving Surgery. Clinical Breast Cancer. Elsevier BV; 2015; 15:381-389 10.1016/j.clbc.2015.02.005
• Surgery improves survival in elderly with breast cancer. A study of 465 patients in a single institution Cite
  Cortadellas T, Córdoba O, Gascón A, Haladjian C, Bernabeu A, Alcalde A, et al. Surgery improves survival in elderly with breast cancer. A study of 465 patients in a single institution. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2015; 41:635-640 10.1016/j.ejso.2015.01.027
• Survival and relapse free period of 2926 unselected older breast cancer patients: A FOCUS cohort study Cite
  Kiderlen M, van de Water W, Bastiaannet E, de Craen AJ, Westendorp RG, van de Velde CJ, et al. Survival and relapse free period of 2926 unselected older breast cancer patients: A FOCUS cohort study. Cancer Epidemiology. Elsevier BV; 2015; 39:42-47 10.1016/j.canep.2014.11.007
• Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial Cite
  Kunkler IH, Williams LJ, Jack WJL, Cameron DA, Dixon JM. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. The Lancet Oncology. Elsevier BV; 2015; 16:266-273 10.1016/s1470-2045(14)71221-5
• Treatment strategies in elderly breast cancer patients: Is there a need for surgery? Cite
  Sierink J, de Castro S, Russell N, Geenen M, Steller E, Vrouenraets B. Treatment strategies in elderly breast cancer patients: Is there a need for surgery?. The Breast. Elsevier BV; 2014; 23:793-798 10.1016/j.breast.2014.08.006
• Deviation from the Standard of Care for Early Breast Cancer in the Elderly: What are the Consequences? Cite
  Sun SX, Hollenbeak CS, Leung AM. Deviation from the Standard of Care for Early Breast Cancer in the Elderly: What are the Consequences?. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2014; 22:2492-2499 10.1245/s10434-014-4290-5
• Older Patients With Early-stage Breast Cancer Cite
  Nagar H, Yan W, Christos P, Chao KC, Nori D, Ravi A. Older Patients With Early-stage Breast Cancer. American Journal of Clinical Oncology. Ovid Technologies (Wolters Kluwer Health); 2017; 40:300-305 10.1097/coc.0000000000000144
• Quality of life among a population-based cohort of older patients with breast cancer Cite
  Neuner JM, Zokoe N, McGinley EL, Pezzin LE, Yen TW, Schapira MM, et al. Quality of life among a population-based cohort of older patients with breast cancer. The Breast. Elsevier BV; 2014; 23:609-616 10.1016/j.breast.2014.06.002
• A population based study of variations in operation rates for breast cancer, of comorbidity and prognosis at diagnosis: Failure to operate for early breast cancer in older women Cite
  Bates T, Evans T, Lagord C, Monypenny I, Kearins O, Lawrence G. A population based study of variations in operation rates for breast cancer, of comorbidity and prognosis at diagnosis: Failure to operate for early breast cancer in older women. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2014; 40:1230-1236 10.1016/j.ejso.2014.06.001
• Risk of Hospitalization According to Chemotherapy Regimen in Early-Stage Breast Cancer Cite
  Barcenas CH, Niu J, Zhang N, Zhang Y, Buchholz TA, Elting LS, et al. Risk of Hospitalization According to Chemotherapy Regimen in Early-Stage Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014; 32:2010-2017 10.1200/jco.2013.49.3676
• Febrile Neutropaenia and Chemotherapy Discontinuation in Women Aged 70 Years or Older Receiving Adjuvant Chemotherapy for Early Breast Cancer Cite
  Adjogatse D, Thanopoulou E, Okines A, Thillai K, Tasker F, Johnston S, et al. Febrile Neutropaenia and Chemotherapy Discontinuation in Women Aged 70 Years or Older Receiving Adjuvant Chemotherapy for Early Breast Cancer. Clinical Oncology. Elsevier BV; 2014; 26:692-696 10.1016/j.clon.2014.05.002
• Cognitive Impairment in Older Patients With Breast Cancer Before Systemic Therapy: Is There an Interaction Between Cancer and Comorbidity? Cite
  Mandelblatt JS, Stern RA, Luta G, McGuckin M, Clapp JD, Hurria A, et al. Cognitive Impairment in Older Patients With Breast Cancer Before Systemic Therapy: Is There an Interaction Between Cancer and Comorbidity?. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014; 32:1909-1918 10.1200/jco.2013.54.2050
• Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus) Cite
  Morgan J, Wyld L, Collins KA, Reed MW. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus). Cochrane Database of Systematic Reviews. Wiley; 2014; 10.1002/14651858.cd004272.pub3
• Axillary dissection versus no axillary dissection in older T1N0 breast cancer patients: 15-Year results of trial and out-trial patients Cite
  Martelli G, Boracchi P, Orenti A, Lozza L, Maugeri I, Vetrella G, et al. Axillary dissection versus no axillary dissection in older T1N0 breast cancer patients: 15-Year results of trial and out-trial patients. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2014; 40:805-812 10.1016/j.ejso.2014.03.029
• Primary endocrine therapy as a treatment for older women with operable breast cancer – A comparison of randomised controlled trial and cohort study findings Cite
  Morgan J, Reed M, Wyld L. Primary endocrine therapy as a treatment for older women with operable breast cancer – A comparison of randomised controlled trial and cohort study findings. European Journal of Surgical Oncology (EJSO). Elsevier BV; 2014; 40:676-684 10.1016/j.ejso.2014.02.224
• Impact of comorbidity on outcome of older breast cancer patients: a FOCUS cohort study Cite
  Kiderlen M, de Glas NA, Bastiaannet E, van de Water W, de Craen AJM, Guicherit OR, et al. Impact of comorbidity on outcome of older breast cancer patients: a FOCUS cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2014; 145:185-192 10.1007/s10549-014-2917-7
• The use of adjuvant endocrine breast cancer therapy in the oldest old Cite
  Güth U, Myrick ME, Kandler C, Vetter M. The use of adjuvant endocrine breast cancer therapy in the oldest old. The Breast. Elsevier BV; 2013; 22:863-868 10.1016/j.breast.2013.03.001
• Is lack of surgery for older breast cancer patients in the UK explained by patient choice or poor health? A prospective cohort study Cite
  Lavelle K, Sowerbutts AM, Bundred N, Pilling M, Degner L, Stockton C, et al. Is lack of surgery for older breast cancer patients in the UK explained by patient choice or poor health? A prospective cohort study. British Journal of Cancer. Springer Science and Business Media LLC; 2013; 110:573-583 10.1038/bjc.2013.734
• Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity Cite
  Lotrionte M, Biondi-Zoccai G, Abbate A, Lanzetta G, D'Ascenzo F, Malavasi V, et al. Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity. The American Journal of Cardiology. Elsevier BV; 2013; 112:1980-1984 10.1016/j.amjcard.2013.08.026
• Hormone Receptor-Negative Breast Cancer: Undertreatment of Patients Over 80 Cite
  Weiss A, Noorbaksh A, Tokin C, Chang D, Blair SL. Hormone Receptor-Negative Breast Cancer: Undertreatment of Patients Over 80. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2013; 20:3274-3278 10.1245/s10434-013-3115-2
• Familial risk of early and late onset cancer: nationwide prospective cohort study Cite
  Kharazmi E, Fallah M, Sundquist K, Hemminki K. Familial risk of early and late onset cancer: nationwide prospective cohort study. BMJ. BMJ; 2012; 345:e8076-e8076 10.1136/bmj.e8076
• Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer Cite
  Chen J, Long JB, Hurria A, Owusu C, Steingart RM, Gross CP. Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer. Journal of the American College of Cardiology. Elsevier BV; 2012; 60:2504-2512 10.1016/j.jacc.2012.07.068
• The Surgical Treatment of Breast Cancer in the Elderly: A Single Institution Comparative Review of 5235 Patients with 1028 Patients ≥70 years Cite
  Kaur P, Santillan AA, McGuire K, Turaga KK, Shamehdi C, Meade T, et al. The Surgical Treatment of Breast Cancer in the Elderly: A Single Institution Comparative Review of 5235 Patients with 1028 Patients ≥70 years. The Breast Journal. Wiley; 2012; 18:428-435 10.1111/j.1524-4741.2012.01272.x
• Factors affecting the delivery of adjuvant/neoadjuvant chemotherapy in older women with breast cancer Cite
  O'Connor TL, Edge SB, Kossoff EB, Groman A, Wilding GE, Ademuyiwa FO, et al. Factors affecting the delivery of adjuvant/neoadjuvant chemotherapy in older women with breast cancer. Journal of Geriatric Oncology. Elsevier BV; 2012; 3:320-328 10.1016/j.jgo.2012.06.006
• Patients younger than 40years old and older than 70years old affected by ER(−)/PR(−)/HER2(−) breast cancer have low survival rates: Results of a mono-institutional retrospective analysis Cite
  Sanpaolo P, Barbieri V, Genovesi D, Fusco V, Ausili Cèfaro G, Audisio RA. Patients younger than 40years old and older than 70years old affected by ER(−)/PR(−)/HER2(−) breast cancer have low survival rates: Results of a mono-institutional retrospective analysis. Journal of Geriatric Oncology. Elsevier BV; 2012; 3:312-319 10.1016/j.jgo.2012.06.001
• Biology, Treatment, and Outcome in Very Young and Older Women with DCIS Cite
  Alvarado R, Lari SA, Roses RE, Smith BD, Yang W, Mittendorf EA, et al. Biology, Treatment, and Outcome in Very Young and Older Women with DCIS. Annals of Surgical Oncology. Springer Science and Business Media LLC; 2012; 19:3777-3784 10.1245/s10434-012-2413-4
• Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: A systematic review of randomized controlled trials Cite
  Brollo J, Curigliano G, Disalvatore D, Marrone BF, Criscitiello C, Bagnardi V, et al. Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: A systematic review of randomized controlled trials. Cancer Treatment Reviews. Elsevier BV; 2013; 39:44-50 10.1016/j.ctrv.2012.03.009
• Invasive lobular breast cancer: subtypes and outcome Cite
  Iorfida M, Maiorano E, Orvieto E, Maisonneuve P, Bottiglieri L, Rotmensz N, et al. Invasive lobular breast cancer: subtypes and outcome. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2012; 133:713-723 10.1007/s10549-012-2002-z
• Local Control, Toxicity, and Cosmesis in Women >70 Years Enrolled in the American Society of Breast Surgeons Accelerated Partial Breast Irradiation Registry Trial Cite
  Khan AJ, Vicini FA, Beitsch P, Goyal S, Kuerer HM, Keisch M, et al. Local Control, Toxicity, and Cosmesis in Women >70 Years Enrolled in the American Society of Breast Surgeons Accelerated Partial Breast Irradiation Registry Trial. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012; 84:323-330 10.1016/j.ijrobp.2011.12.027
• A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up Cite
  Johnston S, Kenny F, Syed B, Robertson J, Pinder S, Winterbottom L, et al. A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up. Annals of Oncology. Elsevier BV; 2012; 23:2296-2300 10.1093/annonc/mdr630
• Association Between Age at Diagnosis and Disease-Specific Mortality Among Postmenopausal Women With Hormone Receptor–Positive Breast Cancer Cite
  van de Water W, Markopoulos C, van de Velde CJH, Seynaeve C, Hasenburg A, Rea D, et al. Association Between Age at Diagnosis and Disease-Specific Mortality Among Postmenopausal Women With Hormone Receptor–Positive Breast Cancer. JAMA. American Medical Association (AMA); 2012; 307 10.1001/jama.2012.84
• Quantifying differences in breast cancer survival between England and Norway Cite
  Lambert PC, Holmberg L, Sandin F, Bray F, Linklater KM, Purushotham A, et al. Quantifying differences in breast cancer survival between England and Norway. Cancer Epidemiology. Elsevier BV; 2011; 35:526-533 10.1016/j.canep.2011.04.003
• Early operable breast cancer in elderly women treated with an aromatase inhibitor letrozole as sole therapy Cite
  Balakrishnan A, Ravichandran D. Early operable breast cancer in elderly women treated with an aromatase inhibitor letrozole as sole therapy. British Journal of Cancer. Springer Science and Business Media LLC; 2011; 105:1825-1829 10.1038/bjc.2011.470
• Faculty Opinions recommendation of Improvement in breast cancer outcomes over time: are older women missing out? Cite
  Wildiers H. Faculty Opinions recommendation of Improvement in breast cancer outcomes over time: are older women missing out?. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature. Faculty Opinions Ltd; 2012; 10.3410/f.14267132.15779274
• Moderate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer Risk Cite
  Chen WY, Rosner B, Hankinson SE, Colditz GA, Willett WC. Moderate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer Risk. JAMA. American Medical Association (AMA); 2011; 306:1884 10.1001/jama.2011.1590
• Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy Cite
  Arvold ND, Taghian AG, Niemierko A, Abi Raad RF, Sreedhara M, Nguyen PL, et al. Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:3885-3891 10.1200/jco.2011.36.1105
• Mortality Rates Among Early-Stage Hormone Receptor-Positive Breast Cancer Patients: A Population-Based Cohort Study in Denmark Cite
  Christiansen P, Bjerre K, Ejlertsen B, Jensen M, Rasmussen BB, Laenkholm A, et al. Mortality Rates Among Early-Stage Hormone Receptor-Positive Breast Cancer Patients: A Population-Based Cohort Study in Denmark. JNCI Journal of the National Cancer Institute. Oxford University Press (OUP); 2011; 103:1363-1372 10.1093/jnci/djr299
• Invasive lobular carcinoma: response to neoadjuvant letrozole therapy Cite
  Dixon JM, Renshaw L, Dixon J, Thomas J. Invasive lobular carcinoma: response to neoadjuvant letrozole therapy. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 130:871-877 10.1007/s10549-011-1735-4
• Radiation and survival in women over 70 with T1 N0 M0 ER-negative breast cancer from 1990 to 2007: A population-based analysis. Cite
  Wojcieszynski AP, Shen X, Mishra MV, Anne PR, Showalter TN. Radiation and survival in women over 70 with T1 N0 M0 ER-negative breast cancer from 1990 to 2007: A population-based analysis.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:1037-1037 10.1200/jco.2011.29.15_suppl.1037
• Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer Cite
  Buist DSM, Abraham LA, Barlow WE, Krishnaraj A, Holdridge RC, Sickles EA, et al. Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 124:863-873 10.1007/s10549-010-1106-6
• Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age Cite
  van der Kolk DM, de Bock GH, Leegte BK, Schaapveld M, Mourits MJE, de Vries J, et al. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 124:643-651 10.1007/s10549-010-0805-3
• Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis Cite
  Punglia RS, Saito AM, Neville BA, Earle CC, Weeks JC. Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis. BMJ. BMJ; 2010; 340:c845-c845 10.1136/bmj.c845
• Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study Cite
  Kelly CM, Juurlink DN, Gomes T, Duong-Hua M, Pritchard KI, Austin PC, et al. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ. BMJ; 2010; 340:c693-c693 10.1136/bmj.c693
• Racial disparities in the use of radiotherapy after breast-conserving surgery: A national Medicare study Cite
  Smith GL, Shih YT, Xu Y, Giordano SH, Smith BD, Perkins GH, et al. Racial disparities in the use of radiotherapy after breast-conserving surgery: A national Medicare study. Cancer. Wiley; 2010; 116:734-741 10.1002/cncr.24741
• Breast Cancer Recurrence in Older Women Five to Ten Years after Diagnosis Cite
  Bosco JL, Lash TL, Prout MN, Buist DS, Geiger AM, Haque R, et al. Breast Cancer Recurrence in Older Women Five to Ten Years after Diagnosis. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2009; 18:2979-2983 10.1158/1055-9965.epi-09-0607
• Chocolate consumption and bone density in older women Cite
  Hodgson JM, Devine A, Burke V, Dick IM, Prince RL. Chocolate consumption and bone density in older women. The American Journal of Clinical Nutrition. Oxford University Press (OUP); 2008; 87:175-180 10.1093/ajcn/87.1.175
• Local Recurrence after Breast Cancer Affects Specific Survival Differently according to Patient Age Cite
  Courdi A, Doyen J, Gal J, Chamorey E. Local Recurrence after Breast Cancer Affects Specific Survival Differently according to Patient Age. Oncology. S. Karger AG; 2010; 79:349-354 10.1159/000323483